IBDEI1D3 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22011,0)
 ;;=97750^^71^939^6^^^^1
 ;;^UTILITY(U,$J,358.3,22011,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22011,1,2,0)
 ;;=2^97750
 ;;^UTILITY(U,$J,358.3,22011,1,3,0)
 ;;=3^Extrem Perf Testing,Ea 15min
 ;;^UTILITY(U,$J,358.3,22012,0)
 ;;=97161^^71^939^12^^^^1
 ;;^UTILITY(U,$J,358.3,22012,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22012,1,2,0)
 ;;=2^97161
 ;;^UTILITY(U,$J,358.3,22012,1,3,0)
 ;;=3^PT Evaluation,Low Complexity
 ;;^UTILITY(U,$J,358.3,22013,0)
 ;;=97162^^71^939^13^^^^1
 ;;^UTILITY(U,$J,358.3,22013,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22013,1,2,0)
 ;;=2^97162
 ;;^UTILITY(U,$J,358.3,22013,1,3,0)
 ;;=3^PT Evaluation,Moderate Complexity
 ;;^UTILITY(U,$J,358.3,22014,0)
 ;;=97163^^71^939^11^^^^1
 ;;^UTILITY(U,$J,358.3,22014,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22014,1,2,0)
 ;;=2^97163
 ;;^UTILITY(U,$J,358.3,22014,1,3,0)
 ;;=3^PT Evaluation,High Complexity
 ;;^UTILITY(U,$J,358.3,22015,0)
 ;;=97164^^71^939^14^^^^1
 ;;^UTILITY(U,$J,358.3,22015,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22015,1,2,0)
 ;;=2^97164
 ;;^UTILITY(U,$J,358.3,22015,1,3,0)
 ;;=3^PT Re-Evaluation
 ;;^UTILITY(U,$J,358.3,22016,0)
 ;;=97165^^71^939^8^^^^1
 ;;^UTILITY(U,$J,358.3,22016,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22016,1,2,0)
 ;;=2^97165
 ;;^UTILITY(U,$J,358.3,22016,1,3,0)
 ;;=3^OT Evaluation,Low Complexity
 ;;^UTILITY(U,$J,358.3,22017,0)
 ;;=97166^^71^939^9^^^^1
 ;;^UTILITY(U,$J,358.3,22017,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22017,1,2,0)
 ;;=2^97166
 ;;^UTILITY(U,$J,358.3,22017,1,3,0)
 ;;=3^OT Evaluation,Moderate Complexity
 ;;^UTILITY(U,$J,358.3,22018,0)
 ;;=97167^^71^939^7^^^^1
 ;;^UTILITY(U,$J,358.3,22018,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22018,1,2,0)
 ;;=2^97167
 ;;^UTILITY(U,$J,358.3,22018,1,3,0)
 ;;=3^OT Evaluation,High Complexity
 ;;^UTILITY(U,$J,358.3,22019,0)
 ;;=97168^^71^939^10^^^^1
 ;;^UTILITY(U,$J,358.3,22019,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22019,1,2,0)
 ;;=2^97168
 ;;^UTILITY(U,$J,358.3,22019,1,3,0)
 ;;=3^OT Re-Evaluation
 ;;^UTILITY(U,$J,358.3,22020,0)
 ;;=96112^^71^939^4^^^^1
 ;;^UTILITY(U,$J,358.3,22020,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22020,1,2,0)
 ;;=2^96112
 ;;^UTILITY(U,$J,358.3,22020,1,3,0)
 ;;=3^Developmental Test Admin,1st Hr
 ;;^UTILITY(U,$J,358.3,22021,0)
 ;;=96113^^71^939^5^^^^1
 ;;^UTILITY(U,$J,358.3,22021,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22021,1,2,0)
 ;;=2^96113
 ;;^UTILITY(U,$J,358.3,22021,1,3,0)
 ;;=3^Developmental Test Admin,Ea Addl 30 min
 ;;^UTILITY(U,$J,358.3,22022,0)
 ;;=64479^^71^940^6^^^^1
 ;;^UTILITY(U,$J,358.3,22022,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22022,1,2,0)
 ;;=2^64479
 ;;^UTILITY(U,$J,358.3,22022,1,3,0)
 ;;=3^INJ Epidural, foramen, C/T
 ;;^UTILITY(U,$J,358.3,22023,0)
 ;;=64480^^71^940^8^^^^1
 ;;^UTILITY(U,$J,358.3,22023,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22023,1,2,0)
 ;;=2^64480
 ;;^UTILITY(U,$J,358.3,22023,1,3,0)
 ;;=3^INJ Epidural,C/T Ea Addl Level
 ;;^UTILITY(U,$J,358.3,22024,0)
 ;;=64483^^71^940^7^^^^1
 ;;^UTILITY(U,$J,358.3,22024,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22024,1,2,0)
 ;;=2^64483
 ;;^UTILITY(U,$J,358.3,22024,1,3,0)
 ;;=3^INJ Epidural, foramen, L/S
 ;;^UTILITY(U,$J,358.3,22025,0)
 ;;=64484^^71^940^5^^^^1
 ;;^UTILITY(U,$J,358.3,22025,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22025,1,2,0)
 ;;=2^64484
 ;;^UTILITY(U,$J,358.3,22025,1,3,0)
 ;;=3^INJ Epidural, L/S Ea Addl Level
